S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Insiders Say New “Parallel Economy” Is Wave Of Future (Ad)pixel
Closing prices for crude oil, gold and other commodities
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
NASDAQ:VTVT

vTv Therapeutics - VTVT Earnings Date, Estimates & Call Transcripts

$1.17
-0.03 (-2.50%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.12
$1.23
50-Day Range
$0.65
$1.20
52-Week Range
$0.38
$2.17
Volume
406,836 shs
Average Volume
541,576 shs
Market Capitalization
$105.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Earnings Summary

Upcoming
Earnings Date
Aug. 10Estimated
Actual EPS
(May. 12)
-$0.10 Missed By -$0.02
Consensus EPS
(May. 12)
-$0.08
Last Year's Q2 EPS
(5/5/2021)
-$0.09
Skip Charts & View Estimated and Actual Earnings Data

VTVT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VTVT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

vTv Therapeutics Analyst Forecasts

Current Year EPS Consensus Estimate: $-0.31 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS

VTVT Earnings Date and Information

vTv Therapeutics last released its earnings results on May 12th, 2022. The biotechnology company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. The firm earned $2 million during the quarter. vTv Therapeutics has generated ($0.24) earnings per share over the last year (($0.24) diluted earnings per share). Earnings for vTv Therapeutics are expected to decrease in the coming year, from ($0.31) to ($0.38) per share. vTv Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 10th, 2022 based off prior year's report dates.

vTv Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2022
(Estimated)
        
5/12/2022Q1 2022($0.08)($0.10)($0.02)($0.10)$2.00 million
3/29/2022Q4 2021($0.08)($0.08)($0.05)$1.00 million$0.01 million
11/9/20219/30/2021($0.07)($0.02)+$0.05($0.02)$1.30 million$3.00 million
8/4/20216/30/2021($0.07)($0.01)+$0.06($0.01)$1.00 million$0.01 million
5/5/2021Q1 2021($0.06)($0.09)($0.03)($0.10)$0.80 million$0.99 million
2/24/202112/31/2020($0.06)$0.02+$0.08$0.02$3.30 million$6.40 million
11/5/20209/30/2020($0.11)($0.03)+$0.08($0.03)$0.01 million  
8/3/20206/30/2020($0.10)($0.08)+$0.02($0.09)
5/7/20203/31/2020($0.10)($0.11)($0.01)($0.11)$0.01 million
2/20/2020Q4 2019($0.10)($0.11)($0.01)($0.09)$1.26 million$0.01 million
10/30/2019Q3 2019($0.11)($0.10)+$0.01($0.07)$1.69 million$0.01 million
7/31/2019Q2 2019($0.11)($0.09)+$0.02($0.08)$1.63 million$1.83 million
5/1/2019Q1 2019($0.26)($0.26)($0.26)$0.92 million
2/27/2019Q4 2018($0.11)($0.10)+$0.01($0.10)$2.07 million$4.52 million
11/8/2018Q3($0.12)($0.06)+$0.06($0.06)$2.06 million$3.38 million
8/3/2018Q2 2018($0.25)($0.29)($0.04)($0.27)$2.46 million$2.47 million
5/15/2018Q1 2018($0.26)($0.3040)($0.0440)($0.30)$3.14 million$2.06 million
2/27/2018Q4 2017($0.41)($0.44)($0.03)($0.44)$0.10 million$0.23 million
11/1/2017Q3 2017($0.40)($0.38)+$0.02($0.38)$0.19 million$0.02 million
8/2/2017Q2 2017($0.43)($0.4090)+$0.0210($0.41)$0.19 million$0.01 million
5/3/2017Q1 2017($0.4430)($0.4350)+$0.0080($0.44)$0.20 million$0.03 million
2/27/2017Q4 2016($0.14)($0.42)($0.28)($0.42)$15.20 million$0.04 million
11/2/2016Q3 2016($0.42)($0.41)+$0.01($0.41)$0.10 million$0.04 million
8/2/2016Q2 2016($0.58)($0.47)+$0.11($0.47)$0.18 million
5/12/2016Q1 2016($0.54)($0.42)+$0.12($0.42)$0.38 million
3/1/2016Q4 2015($0.41)($0.35)+$0.06($0.35)$0.03 million$0.23 million
11/12/2015Q3 2015($0.45)($0.49)($0.04)($0.49)$0.13 million












vTv Therapeutics Earnings - Frequently Asked Questions

When is vTv Therapeutics's earnings date?

vTv Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 10th, 2022 based off last year's report dates. Learn more on VTVT's earnings history.

Did vTv Therapeutics beat their earnings estimates last quarter?

In the previous quarter, vTv Therapeutics (NASDAQ:VTVT) missed the analysts' consensus estimate of ($0.08) by $0.02 with a reported earnings per share (EPS) of ($0.10). Learn more on analysts' earnings estimate vs. VTVT's actual earnings.

How much revenue does vTv Therapeutics generate each year?

vTv Therapeutics (NASDAQ:VTVT) has a recorded annual revenue of $4.01 million.

How much profit does vTv Therapeutics generate each year?

vTv Therapeutics (NASDAQ:VTVT) has a recorded net income of -$12.99 million. VTVT has generated -$0.24 earnings per share over the last four quarters.

What is vTv Therapeutics's EPS forecast for next year?

vTv Therapeutics's earnings are expected to decrease from ($0.31) per share to ($0.38) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:VTVT) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.